Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Cameron Roth

Hand Surgery Peoria, AZ Medical Doctor

NPI 1417486556 CMS profile 2988876

6760 W Thunderbird Rd Ste E110, Peoria, AZ 85381

Open in the dashboard

General payments

$9,562

89 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Cameron Roth of Peoria, AZ is reported in the CMS Open Payments database as having received $9,562 across 89 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,909 22
2024 General $2,878 20
2023 General $2,007 30
2022 General $2,308 12
2021 General $176 2
2020 General $159 2
2019 General $125 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Cameron Roth
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Cameron Roth were reported at $1,909. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Cameron Roth Hand Surgery median Middle half National median
2019 $125 $383 $106–$1,905 $163
2020 $159 $172 $51–$1,268 $114
2021 $176 $263 $71–$1,591 $132
2022 $2,308 $336 $87–$1,938 $149
2023 $2,007 $233 $81–$1,114 $160
2024 $2,878 $258 $88–$1,203 $164
2025 $1,909 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $1,903 20 payments
  2. AxoGen $1,898 7 payments
  3. Acumed LLC $1,325 6 payments
  4. Arthrex, Inc. $1,137 15 payments
  5. ImpactOrtho, Inc. $764 15 payments
  6. Encore Medical, LP $723 3 payments
  7. DePuy Synthes Sales Inc. $469 5 payments
  8. Zimmer Biomet Holdings, Inc. $233 5 payments
  9. Skeletal Dynamics Inc $227 2 payments
  10. Endo Pharmaceuticals Inc. $138 1 payment
  11. Other $747 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,436 74 payments
  2. Travel and Lodging $4,127 15 payments
Products named General payments · program years 2019–2025
  1. Avance Nerve Graft $1,898 7 payments
  2. ACUMED Screw & Pin $1,325 6 payments
  3. ACUMED Foot & Ankle $1,088 2 payments
  4. ACUMED Hand & Wrist $1,088 2 payments
  5. InFrame Implant $1,088 2 payments
  6. ACUMED Tendon & Ligament $1,088 2 payments
  7. DJO SURGICAL Joint Implants $723 3 payments
  8. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $600 2 payments
  9. DJO SURGICAL Joint Implants $580 1 payment
  10. PANGEA $309 3 payments
  11. Other $4,868 67 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

72

Median for Orthopedic Surgery: 203

Drug cost

$340

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 23 $193
Oxycodone Hcl Generic 49 $147

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 65 billing codes

Paid by Medicare

$90,501

Of which drugs: $1,218

Medicare patients

360

Average age 74

Services billed

1,809

222 women, 138 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Arthritis 66%
Ischemic heart disease 27%
Diabetes 25%
Depression 24%
Chronic kidney disease 22%
Osteoporosis 17%
Cancer 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 65 151 $825
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 65 488 $371

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

89 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record